Guangzhou Haige Communications Group Incorporated (002465.SZ) signed a project contract with its wholly-owned subsidiary.
Hagrid Communication (002465.SZ) announced that the company's wholly-owned subsidiary Guangdong Hagrid Yichuang Technology Co., Ltd. (referred to as "...
Guangzhou Haige Communications Group Incorporated (002465.SZ) announced that its wholly-owned subsidiary, Guangdong Haige Yichuang Technology Co., Ltd. (referred to as "Haige Yichuang"), signed a project contract with Guangzhou Information Investment Co., Ltd. (referred to as "Guangzhou Xintou"). Haige Yichuang and Guangzhou Municipal Engineering Design Research Institute Co., Ltd. (referred to as "Guangzhou Municipal Design Institute") formed a consortium to win the bid for the Guangzhou Municipal Road Pole Renovation Pilot Project (design, construction, equipment procurement and installation). The project includes completing the project's design, equipment procurement and installation, and construction, with a total contract amount of 169 million yuan. Haige Yichuang's contract amount is 161 million yuan, while Guangzhou Municipal Design Institute's contract amount is 7.66 million yuan.
Related Articles
CK LIFE SCIENCES(00775): Positive results achieved in the mid-term analysis of the Phase IIb study of Halneuron in treating chemotherapy-induced neuropathic pain.
Bitcoin winter is coming? Whale Strategy (MSTR.US) pauses buying spree, hoarding $2.2 billion in cash to prepare for winter.
Shanghai Fosun Pharmaceutical (02196) responds to the acquisition of LvGu Pharmaceutical: The confirmatory clinical research on mannitol sodium capsules has been recognized by the Drug Evaluation Center, with a total of 580 cases enrolled.
CK LIFE SCIENCES(00775): Positive results achieved in the mid-term analysis of the Phase IIb study of Halneuron in treating chemotherapy-induced neuropathic pain.
Bitcoin winter is coming? Whale Strategy (MSTR.US) pauses buying spree, hoarding $2.2 billion in cash to prepare for winter.
Shanghai Fosun Pharmaceutical (02196) responds to the acquisition of LvGu Pharmaceutical: The confirmatory clinical research on mannitol sodium capsules has been recognized by the Drug Evaluation Center, with a total of 580 cases enrolled.
